Matches in Wikidata for { <http://www.wikidata.org/entity/Q63574709> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- Q63574709 description "clinical trial" @default.
- Q63574709 description "ensayu clínicu" @default.
- Q63574709 description "klinisch onderzoek" @default.
- Q63574709 description "клінічне випробування" @default.
- Q63574709 description "կլինիկական փորձարկում" @default.
- Q63574709 name "Durvalumab vs Placebo Following Stereotactic Body Radiation Therapy in Early Stage Non-small Cell Lung Cancer Patients" @default.
- Q63574709 type Item @default.
- Q63574709 label "Durvalumab vs Placebo Following Stereotactic Body Radiation Therapy in Early Stage Non-small Cell Lung Cancer Patients" @default.
- Q63574709 prefLabel "Durvalumab vs Placebo Following Stereotactic Body Radiation Therapy in Early Stage Non-small Cell Lung Cancer Patients" @default.
- Q63574709 P1132 Q63574709-36997B1E-B2C7-4F39-BD20-8FDD66929732 @default.
- Q63574709 P1476 Q63574709-B10ACD05-D06F-4E88-8571-28D1C037648E @default.
- Q63574709 P17 Q63574709-0719AC34-C8D1-4155-A011-F89E0D47DFDC @default.
- Q63574709 P17 Q63574709-4672B636-804A-471B-8573-2BBA13B30FAD @default.
- Q63574709 P17 Q63574709-52525370-FAEE-4F44-BA28-3CB2081F9FB1 @default.
- Q63574709 P17 Q63574709-5F23C91B-FA45-4F81-BF45-A9537F18437B @default.
- Q63574709 P17 Q63574709-72BE04D7-5F62-4671-8E1C-F70ADFDAE3DB @default.
- Q63574709 P17 Q63574709-AC1B7584-F7A9-4566-B0AD-970AFC2C3215 @default.
- Q63574709 P17 Q63574709-B1DA74E9-4760-4097-B105-5349D73E2F97 @default.
- Q63574709 P17 Q63574709-BA002214-A8B2-4189-8324-E3291E7B970B @default.
- Q63574709 P17 Q63574709-C7A3C341-300C-4262-850C-F39B47654592 @default.
- Q63574709 P17 Q63574709-D4BC5C3C-37E3-445D-B57F-D19352426E68 @default.
- Q63574709 P17 Q63574709-E72428FF-C5C3-4271-950D-6CBCF1AD354A @default.
- Q63574709 P17 Q63574709-EBF6E9CD-500D-4197-8503-6EB1A8FEBB0C @default.
- Q63574709 P1813 Q63574709-B74C92FA-8659-436A-9F61-AFB1D4A09F21 @default.
- Q63574709 P2899 Q63574709-4EA1D972-4BF2-4F71-857F-FC106146B850 @default.
- Q63574709 P3098 Q63574709-EC55E450-A330-4775-A180-B052473A1B34 @default.
- Q63574709 P31 Q63574709-6762D90B-CE8A-436C-A0EA-C3832E044215 @default.
- Q63574709 P4844 Q63574709-33DC2FE9-DA08-4436-BE3B-3D1F119F369B @default.
- Q63574709 P580 Q63574709-E740487E-1454-4B9B-B899-AF2D946F9EDB @default.
- Q63574709 P582 Q63574709-034B47B6-75A9-4070-9386-994A35F88E9F @default.
- Q63574709 P6099 Q63574709-19FB143A-23FA-4166-AE1B-A4F51AF333D5 @default.
- Q63574709 P8363 Q63574709-A93B97CB-7E3B-4479-89B9-4AEB3D87A955 @default.
- Q63574709 P859 Q63574709-12EF1622-9E5D-4946-8867-E9A706E84578 @default.
- Q63574709 P1132 "+630" @default.
- Q63574709 P1476 "A Phase III, Randomized, Placebo-controlled, Double-blind, Multi-center, International Study of Durvalumab Following Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients With Unresected Stage I/II, Lymph-node Negative Non-small Cell Lung Cancer (PACIFIC-4/RTOG-3515)" @default.
- Q63574709 P17 Q142 @default.
- Q63574709 P17 Q145 @default.
- Q63574709 P17 Q16 @default.
- Q63574709 P17 Q17 @default.
- Q63574709 P17 Q183 @default.
- Q63574709 P17 Q29 @default.
- Q63574709 P17 Q30 @default.
- Q63574709 P17 Q31 @default.
- Q63574709 P17 Q36 @default.
- Q63574709 P17 Q38 @default.
- Q63574709 P17 Q55 @default.
- Q63574709 P17 Q801 @default.
- Q63574709 P1813 "PACIFIC-4" @default.
- Q63574709 P2899 "+18" @default.
- Q63574709 P3098 "NCT03833154" @default.
- Q63574709 P31 Q30612 @default.
- Q63574709 P4844 Q19904005 @default.
- Q63574709 P580 "2019-03-06T00:00:00Z" @default.
- Q63574709 P582 "2023-10-02T00:00:00Z" @default.
- Q63574709 P6099 Q42824827 @default.
- Q63574709 P8363 Q78089383 @default.
- Q63574709 P859 Q731938 @default.